Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Jan;225(1):88–96. doi: 10.1097/00000658-199701000-00010

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

L Ellegård 1, I Bosaeus 1, S Nordgren 1, B A Bengtsson 1
PMCID: PMC1190610  PMID: 8998124

Abstract

OBJECTIVE: The authors investigate the effects of low dose recombinant human growth hormone (rhGH) on body composition and absorptive capacity in patients with short bowel syndrome from Crohn's disease. SUMMARY BACKGROUND DATA: Patients with short bowel syndrome usually are malnourished because of malabsorption. The anabolic effects of high doses of rhGH have been tested in different clinical catabolic conditions, recently including patients with short bowel syndrome. The authors have investigated the effects of low-dose rhGH in short bowel syndrome in a placebo-controlled crossover clinical trial. METHODS: Ten patients were treated with daily subcutaneous doses of rhGH/placebo (0.5 international units/kg-1 per week-1 = 0.024 mg/kg-1 per day-1) for 8 weeks in a randomized, double-blind, placebo-controlled crossover clinical trial with a minimum of 12 weeks wash-out. Absorptive capacity and biochemical parameters were investigated in a metabolic ward before treatment and during first and last week of treatment. Body composition was determined by DEXA-Scan (Lunar DPX, Scanexport Medical, Helsingborg, Sweden), impedance analysis, and whole body potassium counting. RESULTS: Low-dose rhGH doubled serum levels of insulin-like growth factor-1 (IGF-1) and increased body weight, lean body mass, and total body potassium by 5% (p < 0.05). Fat-free mass and total body water increased by 6% (p = 0.008). Increases in IGF-1 levels correlated with increases in fat-free mass (r = 0.77, p < 0.02). No significant changes in absorptive capacity of water, energy, or protein were detected. CONCLUSION: Eight weeks of low-dose rhGH treatment leads to increases in body weight, lean body mass, and fat-free mass in patients with short bowel syndrome, correlated to increases in IGF-1 levels.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson H., Bosaeus I., Brummer R. J., Fasth S., Hultén L., Magnusson O., Strauss B. Nutritional and metabolic consequences of extensive bowel resection. Dig Dis. 1986;4(4):193–202. doi: 10.1159/000171149. [DOI] [PubMed] [Google Scholar]
  2. Bengtsson B. A., Edén S., Lönn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tölli J., Sjöström L., Isaksson O. G. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993 Feb;76(2):309–317. doi: 10.1210/jcem.76.2.8432773. [DOI] [PubMed] [Google Scholar]
  3. Binnerts A., Wilson J. H., Lamberts S. W. The effects of human growth hormone administration in elderly adults with recent weight loss. J Clin Endocrinol Metab. 1988 Dec;67(6):1312–1316. doi: 10.1210/jcem-67-6-1312. [DOI] [PubMed] [Google Scholar]
  4. Booth I. W. Enteral nutrition as primary therapy in short bowel syndrome. Gut. 1994 Jan;35(1 Suppl):S69–S72. doi: 10.1136/gut.35.1_suppl.s69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brevinge H., Berglund B., Bosaeus I., Tölli J., Nordgren S., Lundholm K. Exercise capacity in patients undergoing proctocolectomy and small bowel resection for Crohn's disease. Br J Surg. 1995 Aug;82(8):1040–1045. doi: 10.1002/bjs.1800820813. [DOI] [PubMed] [Google Scholar]
  6. Brummer R. J., Rosén T., Bengtsson B. A. Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders. Acta Endocrinol (Copenh) 1993 Jun;128 (Suppl 2):30–36. [PubMed] [Google Scholar]
  7. Byrne T. A., Morrissey T. B., Gatzen C., Benfell K., Nattakom T. V., Scheltinga M. R., LeBoff M. S., Ziegler T. R., Wilmore D. W. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg. 1993 Oct;218(4):400–418. doi: 10.1097/00000658-199310000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Byrne T. A., Persinger R. L., Young L. S., Ziegler T. R., Wilmore D. W. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg. 1995 Sep;222(3):243–255. doi: 10.1097/00000658-199509000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Catignani G. L., Bieri J. G. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 1983 Apr;29(4):708–712. [PubMed] [Google Scholar]
  10. Hawker F. H., Stewart P. M., Baxter R. C., Borkmann M., Tan K., Caterson I. D., McWilliam D. B. Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med. 1987 Aug;15(8):732–736. doi: 10.1097/00003246-198708000-00004. [DOI] [PubMed] [Google Scholar]
  11. Jiang Z. M., He G. Z., Zhang S. Y., Wang X. R., Yang N. F., Zhu Y., Wilmore D. W. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg. 1989 Oct;210(4):513–525. doi: 10.1097/00000658-198910000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaiser F. E., Silver A. J., Morley J. E. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc. 1991 Mar;39(3):235–240. doi: 10.1111/j.1532-5415.1991.tb01643.x. [DOI] [PubMed] [Google Scholar]
  13. Rudman D., Feller A. G., Nagraj H. S., Gergans G. A., Lalitha P. Y., Goldberg A. F., Schlenker R. A., Cohn L., Rudman I. W., Mattson D. E. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1–6. doi: 10.1056/NEJM199007053230101. [DOI] [PubMed] [Google Scholar]
  14. Salomon F., Cuneo R. C., Hesp R., Sönksen P. H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989 Dec 28;321(26):1797–1803. doi: 10.1056/NEJM198912283212605. [DOI] [PubMed] [Google Scholar]
  15. Sandberg A. S., Andersson H., Hallgren B., Hasselblad K., Isaksson B., Hultén L. Experimental model for in vivo determination of dietary fibre and its effect on the absorption of nutrients in the small intestine. Br J Nutr. 1981 Mar;45(2):283–294. doi: 10.1079/bjn19810105. [DOI] [PubMed] [Google Scholar]
  16. Ward H. C., Halliday D., Sim A. J. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg. 1987 Jul;206(1):56–61. doi: 10.1097/00000658-198707000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ziegler T. R., Gatzen C., Wilmore D. W. Strategies for attenuating protein-catabolic responses in the critically ill. Annu Rev Med. 1994;45:459–480. doi: 10.1146/annurev.med.45.1.459. [DOI] [PubMed] [Google Scholar]
  18. Ziegler T. R., Rombeau J. L., Young L. S., Fong Y., Marano M., Lowry S. F., Wilmore D. W. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab. 1992 Apr;74(4):865–873. doi: 10.1210/jcem.74.4.1548352. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES